<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678236</url>
  </required_header>
  <id_info>
    <org_study_id>20070237</org_study_id>
    <nct_id>NCT00678236</nct_id>
  </id_info>
  <brief_title>A Migration and Bone Density Study Comparing 2 Types of Bone Cement in the OptiPac Bone Cement Mixing System</brief_title>
  <official_title>A Migration and Bone Density Study Comparing Refobacin Bone Cement R vs. Refobacin Plus Bone Cement in the OptiPac Bone Cement Mixing System. A Prospective Randomized Study on Primary Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this scientific study is to determine whether there are differences in early&#xD;
      migration and prosthesis-near bone density when a standard knee prosthesis is fixed with&#xD;
      Refobacin Bone Cement R or with Refobacin Plus Bone Cement. Migration will be evaluated with&#xD;
      RSA and bone density around the prosthesis with DEXA. The study will be successful if the&#xD;
      prosthesis is fixed and remains in place throughout the entire period of the study, that is,&#xD;
      that there is no increasing migration as measured by RSA. The cement type that ensures the&#xD;
      largest number of solidly fixed prostheses during the two-year evaluation period will be &quot;the&#xD;
      best&quot;.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Loosening of prosthetic components continues to play a large role in total knee alloplasty&#xD;
      (TKA) and need for revision. Osteolysis is an important part of prosthesis loosening, but we&#xD;
      still do not completely understand the mechanism. Research has shown that mechanical factors&#xD;
      such as weak bone cement and poor contact between cement/bone or cement/implant interphase&#xD;
      contribute to loosening of implants. Survival of cemented TKA components also depend on a&#xD;
      careful balancing of soft tissues around the knee, repair of lower extremity dislocations,&#xD;
      design of the prosthesis and the level of patients' activities. Sclerosis of the proximal&#xD;
      tibia can present a problem with regard to getting the cement to penetrate into the bone.&#xD;
      Poor operative technique, such as high volume or high pressure lavage of the prepared bone&#xD;
      surface, can result in reduced penetration of cement into the spongiosa and early failure of&#xD;
      the prosthesis, measured as progressive radiolucent lines (RLLs). En tourniquet counter acts&#xD;
      bleeding at the implant site and provides for better penetration of cement into the&#xD;
      trabeculae of the bone. If the bone surface at the implantation site is contaminated with&#xD;
      blood before the cement is applied, the shear strength in the bone/cement interphase can be&#xD;
      reduced by up to 50%.&#xD;
&#xD;
      In prosthesis used in this study includes a tibial plateau with a central stem with&#xD;
      stabilizing wings, the bottom surface of which is recessed by about 1 mm, so that a pocket is&#xD;
      formed surrounded by a lip that provides for an even thickness of the cement layer beneath&#xD;
      the tibial plateau. This assures that the cement is pressed down into the spongiosa during&#xD;
      fixation of the implant. This design doubles the penetration of the cement compared with&#xD;
      prostheses without a depressed baseplate. The company behind this design has had a successful&#xD;
      follow-up of this system for more than 15 years. A good cement/implant interphase lessens the&#xD;
      risk of penetration of debris into the interphase and thus reduces the risk for the&#xD;
      development of osteolysis and aseptic loosening of the implant.&#xD;
&#xD;
      Fixation of knee alloplasties is done in 70% of cases with use of cement. It is uncertain&#xD;
      whether there is a difference in the long-term survival of knee prostheses with the two types&#xD;
      of cement used in this project. Both types of cement in this study are used today in knee&#xD;
      surgery with good, short-term clinical results. It is important to investigate new types of&#xD;
      cement in order to assure future patients the best possible results after knee alloplasty and&#xD;
      fewer re-operations.&#xD;
&#xD;
      The goal of this scientific study is to determine whether there are differences in early&#xD;
      migration and prosthesis-near bone density when a standard knee prosthesis is fixed with&#xD;
      Refobacin Bone Cement R or with Refobacin Plus Bone Cement. Migration will be evaluated with&#xD;
      RSA and bone density around the prosthesis with DEXA. The study will be successful if the&#xD;
      prosthesis is fixed and remains in place throughout the entire period of the study, that is,&#xD;
      that there is no increasing migration as measured by RSA. The cement type that ensures the&#xD;
      largest number of solidly fixed prostheses during the two-year evaluation period will be &quot;the&#xD;
      best&quot;.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tibial implant migration evaluated by RSA</measure>
    <time_frame>2013</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of Refobacin Bone Cement R vs. Refobacin Plus Bone Cement</measure>
    <time_frame>2013</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Refobacin Bone Cement R</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Refobacin Plus Bone Cement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Refobacin Bone Cement R</intervention_name>
    <description>Insertion of a knee prosthesis fixed by Refobacin Bone Cement R</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Biomet Europe: Refobacin Bone Cement R</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Refobacin Plus Bone Cement</intervention_name>
    <description>Insertion of a knee prosthesis fixed by Refobacin Plus Bone Cement</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Biomet Europe: Refobacin Plus Bone Cement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primary or secondary knee osteoarthritis&#xD;
&#xD;
          -  sufficient bone quality for total knee arthroplasty&#xD;
&#xD;
          -  age above 70 years&#xD;
&#xD;
          -  no upper age limit if the patient is capable&#xD;
&#xD;
          -  informed and written consent&#xD;
&#xD;
          -  patient can only enter the project with one knee&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  neuromuscular or vascular disease in the affected leg&#xD;
&#xD;
          -  preoperatively not found suitable for a knee arthroplasty&#xD;
&#xD;
          -  patients with osteoporosis based on former diagnosis or preoperative DEXA-scan&#xD;
&#xD;
          -  fracture sequelae or previous PTO or previous extensive knee surgery&#xD;
&#xD;
          -  patients with need of a stem-elongation&#xD;
&#xD;
          -  patients who cannot refrain from taking NSAID post-operatively&#xD;
&#xD;
          -  continuous medical treatment with vitamin K antagonists (Warfarin) which is known to&#xD;
             reduce the bon emineral density by a factor of 5&#xD;
&#xD;
          -  patients with metabolic bone disease&#xD;
&#xD;
          -  patients with rheumatoid arthritis&#xD;
&#xD;
          -  postmenopausal women in estrogenic hormone substitution&#xD;
&#xD;
          -  patients with a continuous need of systemic cortisone treatment&#xD;
&#xD;
          -  non-Danish citizenship&#xD;
&#xD;
          -  patients who do not comprehend the Danish language (read and speak)&#xD;
&#xD;
          -  senile dementia&#xD;
&#xD;
          -  alcoholism - defined as men drinking more than 21 units a week and women drinking more&#xD;
             than 14 units a week&#xD;
&#xD;
          -  drug abuse&#xD;
&#xD;
          -  major psychiatric disease&#xD;
&#xD;
          -  metastatic cancer disease and treatment with radiation therapy or chemotherapy&#xD;
&#xD;
          -  severe systemic disease (e.g. hemi paresis and Parkinson disease)&#xD;
&#xD;
          -  systemic hip and spine disease&#xD;
&#xD;
          -  employee at the orthopaedic department, Aarhus University Hospital&#xD;
&#xD;
          -  ongoing case regarding industrial injury insurance of the knee&#xD;
&#xD;
          -  patients with poor dental status (risk of infection)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kjeld Soballe, MD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Center, Aarhus University Hospital, Tage-Hansens Gade 2, 8000 Ã…rhus C, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopaedic Center, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>May 8, 2008</study_first_submitted>
  <study_first_submitted_qc>May 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2008</study_first_posted>
  <last_update_submitted>August 19, 2013</last_update_submitted>
  <last_update_submitted_qc>August 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>RSA</keyword>
  <keyword>Gonarthritis</keyword>
  <keyword>Bone Cement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Cimetidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

